The Biden administration has finalized an $11 million deal to bolster domestic monkeypox vaccine production. Under the agreement, the funds will be granted to Grand River Aseptic Manufacturing to expedite vaccine packaging. (Axios)
Novo Nordisk is forfeiting the U.S. and Canada rights for adult growth hormone deficiency (AGHD) test macimorelin, which will return to original developer Aeterna Zentaris. Aeterna is “delighted to regain full control over macimorelin,” CEO Klaus Paulini said. (Endpoints News)
As innovative treatments become more available, cancer patients are increasingly burdened with financial debt. Cancer patients are 71% more likely than non-cancer patients to face mortgage foreclosure or other financial worries due to the high cost of treatment. (Kaiser Health News)
Even as the Biden administration prepares to roll out a fall COVID-19 vaccination push, funds for local and state vaccination programs have disappeared. “We are watching the dismantling of the hyperlocal infrastructure that actually brought needles to arms in the most vulnerable communities,” said Stephen Thomas, director of the Center for Health Equity at the University of Maryland. (The New York Times)
Unless Congress acts quickly, the government program supplying free COVID-19 tests to Americans will end September 2. The Biden administration plans to shift COVID test costs to health insurers. (MarketWatch)
